BAYLIN TECHNOLOGIES INC (BYL.CA) Fundamental Analysis & Valuation

TSX:BYL • CA0728191051

0.27 CAD
-0.01 (-5.26%)
Last: Mar 12, 2026, 07:00 PM

This BYL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

BYL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 14 industry peers in the Electronic Equipment, Instruments & Components industry. BYL has a bad profitability rating. Also its financial health evaluation is rather negative. BYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. BYL.CA Profitability Analysis

1.1 Basic Checks

  • BYL had negative earnings in the past year.
  • In the past year BYL had a positive cash flow from operations.
  • BYL had negative earnings in each of the past 5 years.
  • In multiple years BYL reported negative operating cash flow during the last 5 years.
BYL.CA Yearly Net Income VS EBIT VS OCF VS FCFBYL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of BYL (-7.64%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.64%
ROE N/A
ROIC N/A
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYL.CA Yearly ROA, ROE, ROICBYL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

  • With a decent Gross Margin value of 42.56%, BYL is doing good in the industry, outperforming 64.29% of the companies in the same industry.
  • BYL's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BYL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
BYL.CA Yearly Profit, Operating, Gross MarginsBYL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1

2. BYL.CA Health Analysis

2.1 Basic Checks

  • BYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BYL has more shares outstanding
  • Compared to 5 years ago, BYL has more shares outstanding
  • BYL has a worse debt/assets ratio than last year.
BYL.CA Yearly Shares OutstandingBYL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BYL.CA Yearly Total Debt VS Total AssetsBYL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -4.76, we must say that BYL is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.76, BYL is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of BYL is 7.50, which is on the high side as it means it would take BYL, 7.50 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.50, BYL is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.5
Altman-Z -4.76
ROIC/WACCN/A
WACC8.73%
BYL.CA Yearly LT Debt VS Equity VS FCFBYL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • BYL has a Current Ratio of 0.87. This is a bad value and indicates that BYL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BYL's Current ratio of 0.87 is on the low side compared to the rest of the industry. BYL is outperformed by 78.57% of its industry peers.
  • BYL has a Quick Ratio of 0.87. This is a bad value and indicates that BYL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.52, BYL is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.52
BYL.CA Yearly Current Assets VS Current LiabilitesBYL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. BYL.CA Growth Analysis

3.1 Past

  • BYL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.87%, which is quite impressive.
  • BYL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.94%.
  • Measured over the past years, BYL shows a very negative growth in Revenue. The Revenue has been decreasing by -11.42% on average per year.
EPS 1Y (TTM)91.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%-19.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.48% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -0.57% on average over the next years.
EPS Next Y37.5%
EPS Next 2Y27.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.76%
Revenue Next 2Y-0.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYL.CA Yearly Revenue VS EstimatesBYL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
BYL.CA Yearly EPS VS EstimatesBYL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

3

4. BYL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BYL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BYL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYL.CA Price Earnings VS Forward Price EarningsBYL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • BYL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BYL is cheaper than 78.57% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BYL is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.52
EV/EBITDA 30.64
BYL.CA Per share dataBYL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • BYL's earnings are expected to grow with 27.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3YN/A

0

5. BYL.CA Dividend Analysis

5.1 Amount

  • No dividends for BYL!.
Industry RankSector Rank
Dividend Yield 0%

BYL.CA Fundamentals: All Metrics, Ratios and Statistics

BAYLIN TECHNOLOGIES INC

TSX:BYL (3/12/2026, 7:00:00 PM)

0.27

-0.01 (-5.26%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-05
Earnings (Next)05-05
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners2.15%
Ins Owner ChangeN/A
Market Cap41.26M
Revenue(TTM)78.87M
Net Income(TTM)-3.38M
Analysts76.67
Price Target0.38 (40.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.61%
Min Revenue beat(2)-18.29%
Max Revenue beat(2)1.06%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF 9.52
P/OCF 9.38
P/B N/A
P/tB N/A
EV/EBITDA 30.64
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.03
FCFY10.51%
OCF(TTM)0.03
OCFY10.66%
SpS0.52
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.64%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.56%
FCFM 5.5%
ROA(3y)-20.62%
ROA(5y)-29.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.78%
GM growth 5Y2.81%
F-Score5
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.5
Debt/EBITDA 17.72
Cap/Depr 2.66%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion 246.53%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.52
Altman-Z -4.76
F-Score5
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)11.25%
Cap/Depr(5y)21.99%
Cap/Sales(3y)0.89%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y37.5%
EPS Next 2Y27.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-6.57%
Revenue growth 5Y-11.42%
Sales Q2Q%-19.1%
Revenue Next Year-5.76%
Revenue Next 2Y-0.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y93.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year362.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y162.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y167.6%
OCF growth 3YN/A
OCF growth 5YN/A

BAYLIN TECHNOLOGIES INC / BYL.CA FAQ

Can you provide the ChartMill fundamental rating for BAYLIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to BYL.CA.


What is the valuation status of BAYLIN TECHNOLOGIES INC (BYL.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to BAYLIN TECHNOLOGIES INC (BYL.CA). This can be considered as Overvalued.


How profitable is BAYLIN TECHNOLOGIES INC (BYL.CA) stock?

BAYLIN TECHNOLOGIES INC (BYL.CA) has a profitability rating of 2 / 10.


What is the financial health of BAYLIN TECHNOLOGIES INC (BYL.CA) stock?

The financial health rating of BAYLIN TECHNOLOGIES INC (BYL.CA) is 1 / 10.